Which of the following are common treatments for lupus?

Which of the following are common treatments for lupus?

• A. Rituximab and cyclophosphamide only
• B. NSAIDs and acetaminophen only
• C. Steroids and hydroxychloroquine only
• D. Supportive care, NSAIDs, steroids, hydroxychloroquine, methotrexate, other immunosuppressives

Answer: (D)

Lupus treatment combines relief of symptoms with suppression of the immune system, and the plan is tailored to how active the disease is and which organs are affected. Common strategies cover both short-term relief and long-term disease management. NSAIDs and acetaminophen help with joint pain and fever, while steroids control inflammation during flares. Hydroxychloroquine is frequently used across many patients to reduce flares and improve long-term outcomes, though it requires regular eye monitoring for potential toxicity. For more persistent or organ-threatening disease, disease-modifying or immunosuppressive agents such as methotrexate, azathioprine, mycophenolate, and other immunosuppressives are added to control disease activity and reduce reliance on steroids. Supportive care—healthy lifestyle, sun protection, vaccination, and management of comorbidities—also plays a crucial role. This broad-and-balanced approach reflects how lupus is managed in real-world practice, making the option that lists supportive care, NSAIDs, steroids, hydroxychloroquine, methotrexate, and other immunosuppressives the best fit. Rituximab and cyclophosphamide are used in specific situations but are not as universally common across the spectrum as the combined regimen described.

Lupus treatment combines relief of symptoms with suppression of the immune system, and the plan is tailored to how active the disease is and which organs are affected. Common strategies cover both short-term relief and long-term disease management. NSAIDs and acetaminophen help with joint pain and fever, while steroids control inflammation during flares. Hydroxychloroquine is frequently used across many patients to reduce flares and improve long-term outcomes, though it requires regular eye monitoring for potential toxicity. For more persistent or organ-threatening disease, disease-modifying or immunosuppressive agents such as methotrexate, azathioprine, mycophenolate, and other immunosuppressives are added to control disease activity and reduce reliance on steroids. Supportive care—healthy lifestyle, sun protection, vaccination, and management of comorbidities—also plays a crucial role. This broad-and-balanced approach reflects how lupus is managed in real-world practice, making the option that lists supportive care, NSAIDs, steroids, hydroxychloroquine, methotrexate, and other immunosuppressives the best fit. Rituximab and cyclophosphamide are used in specific situations but are not as universally common across the spectrum as the combined regimen described.